Deutsche Märkte geschlossen

Smith & Nephew plc (SN.L)

LSE - LSE Verzögerter Preis. Währung in GBp (0.01 GBP)
Zur Watchlist hinzufügen
1.089,50+11,00 (+1,02%)
Börsenschluss: 06:24PM GMT

Smith & Nephew plc

Building 5
Croxley Park Hatters Lane
Watford WD18 8YE
United Kingdom
44 1923 477 100

BrancheMedical Devices

Leitende Angestellte

Ms. Anne-Francoise NesmesCFO & Exec. Director1,71MN/A1972
Dr. Deepak S. Nath Ph.D.CEO & DirectorN/AN/A1973
Mr. Paul ConnollyPres of Global OperationsN/AN/A1968
Mr. Andrew SwiftVP of Investor RelationsN/AN/AN/A
Ms. Helen BarracloughGroup Gen. Counsel, Company Sec. & DirectorN/AN/A1979
Ms. Alison ParkesChief Compliance OfficerN/AN/A1972
Mr. Joe MetzgerSr. VP of Marketing Services & CommunicationsN/AN/AN/A
Ms. Elga LohlerChief HR OfficerN/AN/A1968
Mr. Philip G. CowdyChief Bus. Devel. & Corp. Affairs OfficerN/AN/A1967
Mr. Bradley CannonPres of Orthopaedics, Sports Medicine & ENT and AmericasN/AN/A1968
Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in GBp.


Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Corporate Governance

Smith & Nephew plcs ISS Governance QualityScore, Stand 1. Oktober 2022, lautet 4. Die grundlegenden Scores sind Audit: 6, Vorstand: 6, Shareholderrechte: 1, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.